Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status

References

• Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107:2099–2107.
   PubMed Web of Science ®Google Scholar
• Bjork J, Albin M, Mauritzson N, . Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose-response relations. Leuk Res 2001;25:865–872.
   PubMed Web of Science ®Google Scholar
• Crane MM, Strom SS, Halabi S, . Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev 1996;5:639–644.
   PubMed Web of Science ®Google Scholar
• Davico L, Sacerdote C, Ciccone G, . Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: a population-based study. Cancer Epidemiol Biomarkers Prev 1998;7:1123–1125.
   PubMed Web of Science ®Google Scholar
• Korte JE, Hertz-Picciotto I, Schulz MR, . The contribution of benzene to smoking-induced leukemia. Environ Health Perspect 2000;108:333–339.
   PubMed Web of Science ®Google Scholar
• Moorman AV, Roman E, Cartwright RA, . Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. Br J Cancer 2002;86:60–62.
   PubMed Web of Science ®Google Scholar
• Sandler DP, Shore DL, Anderson JR, . Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst 1993;85:1994–2003.
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487–491.
   PubMed Web of Science ®Google Scholar
• Marsh S, McLeod HL. Cancer pharmacogenetics. Br J Cancer 2004;90:8–11.
   PubMed Web of Science ®Google Scholar
• Nagasubramanian R, Innocenti F, Ratain MJ. Pharmacogenetics in cancer treatment. Annu Rev Med 2003;54:437–452.
   PubMed Web of Science ®Google Scholar
• Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 1991;266:681–687.
   PubMed Web of Science ®Google Scholar
• Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003;17:27–41.
   PubMed Web of Science ®Google Scholar
• de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999;13:768–785.
   PubMed Web of Science ®Google Scholar
• Sunaga N, Kohno T, Shinmura K, . OGG1 protein suppresses G:C– > T:A mutation in a shuttle vector containing 8-hydroxyguanine in human cells. Carcinogenesis 2001;22:1355–1362.
   PubMed Web of Science ®Google Scholar
• Baumann P, West SC. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci 1998;23:247–251.
   PubMed Web of Science ®Google Scholar
• Li Z, Otevrel T, Gao Y, . The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 1995;83:1079–1089.
   PubMed Web of Science ®Google Scholar
• Mari PO, Florea BI, Persengiev SP, . Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA 2006;103:18597–18602.
   PubMed Web of Science ®Google Scholar
• Kaina B, Christmann M, Naumann S, . MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 2007;6:1079–1099.
   PubMed Web of Science ®Google Scholar
• Pegg AE, Fang Q, Loktionova NA. Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair (Amst) 2007;6:1071–1078.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, . Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361–398.
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Muller M, Homolya L, . Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J 1994;8:766–770.
   PubMed Web of Science ®Google Scholar
• Sharom FJ, Yu X, DiDiodato G, . Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem J 1996;320:421–428.
   PubMed Web of Science ®Google Scholar
• D'Alo F, Voso MT, Guidi F, . Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004;89:664–670.
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Balcerczak E, Cebula B, . No influence of 3435C > T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells. Ther Drug Monit 2006;28:707–711.
   PubMed Web of Science ®Google Scholar
• Majumdar S, Mondal BC, Ghosh M, . Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 2008;17:125–132.
   PubMed Web of Science ®Google Scholar
• Rollinson S, Roddam P, Kane E, . Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis 2000;21:43–47.
   PubMed Web of Science ®Google Scholar
• Kim HN, Lee IK, Kim YK, . Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008;140:287–294.
   PubMed Web of Science ®Google Scholar
• Kim HN, Kim NY, Yu L, . Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma. Am J Hematol 2009;84: 821–825.
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716–723.
   Web of Science ®Google Scholar
• Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461–464.
   Web of Science ®Google Scholar
• Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978–989.
   PubMed Web of Science ®Google Scholar
• Wang Y, Spitz MR, Zhu Y, . From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003;2:901–908.
   PubMed Web of Science ®Google Scholar
• Tuimala J, Szekely G, Wikman H, . Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat Res 2004;554:319–333.
   PubMed Web of Science ®Google Scholar
• Crofts F, Taioli E, Trachman J, . Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994;15:2961–2963.
   PubMed Web of Science ®Google Scholar
• Crump C, Chen C, Appelbaum FR, . Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:457–460.
   PubMed Web of Science ®Google Scholar
• Naoe T, Takeyama K, Yokozawa T, . Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000;6:4091–4095.
   PubMed Web of Science ®Google Scholar
• Allan JM, Wild CP, Rollinson S, . Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 2001;98:11592–11597.
   PubMed Web of Science ®Google Scholar
• Haase D, Binder C, Bunger J, . Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002;26:249–254.
   PubMed Web of Science ®Google Scholar
• Basu T, Gale RE, Langabeer S, . Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 1997;349:1450–1451.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194–1210.
   PubMed Web of Science ®Google Scholar
• Robertson IG, Guthenberg C, Mannervik B, . Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Cancer Res 1986;46:2220–2224.
   PubMed Web of Science ®Google Scholar
• Ali-Osman F, Akande O, Antoun G, . Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997;272:10004–10012.
   PubMed Web of Science ®Google Scholar
• Hu X, Xia H, Srivastava SK, . Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997;238:397–402.
   PubMed Web of Science ®Google Scholar
• Pemble S, Schroeder KR, Spencer SR, . Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271–276.
   PubMed Web of Science ®Google Scholar
• Zimniak P, Nanduri B, Pikula S, . Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893–899.
   PubMedGoogle Scholar
• Ashton LJ, Murray JE, Haber M, . Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenet Genomics 2007;17:709–717.
   PubMed Web of Science ®Google Scholar
• Hu JJ, Smith TR, Miller MS, . Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001;22:917–922.
   PubMed Web of Science ®Google Scholar
• Huo X, Lu C, Huang X, . Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol 2009;135:1569–1575.
   PubMed Web of Science ®Google Scholar
• Tang K, Ngoi SM, Gwee PC, . Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002;12:437–450.
   PubMedGoogle Scholar
• Ameyaw MM, Regateiro F, Li T, . MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001;11:217–221.
   PubMedGoogle Scholar